Lucosky Brookman’s client NeurAxis, Inc. (AMEX: NRXS), a pioneering medical technology company specializing in the development of innovative neuromodulation therapies aimed at addressing chronic and debilitating conditions in both children and adults, has successfully priced its underwritten initial public offering. Lucosky Brookman is pleased to represent NeurAxis in this pivotal moment.

Lucosky Brookman congratulates its client Kingswood Investments, a division of Kingswood Capital Partners, LLC, in its role as the sole bookrunner in the successful initial public offering (IPO) of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA). MIRA Pharmaceuticals is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new synthetic THC analog.

MIRA Pharmaceuticals priced its IPO at $7.00 per share, offering 1,275,000 shares of common stock for aggregate gross proceeds of $8.9 million, before deducting underwriting discounts, commissions, and other offering expenses. The company also granted the underwriter a 45-day option to purchase an additional 191,250 shares of common stock at the IPO price, less underwriting discounts and commissions, to cover over-allotments, if any.

The offering is set to close on August 7, 2023, subject to customary closing conditions. In connection with the IPO, MIRA Pharmaceuticals has received approval to list its common stock on the Nasdaq Capital Market, with trading expected to commence on August 3, 2023, under the symbol "MIRA."

MIRA Pharmaceuticals plans to utilize the net proceeds from the IPO to advance its clinical development programs, as well as for working capital and general corporate purposes, demonstrating the company's commitment to its growth and expansion plans.

Lucosky Brookman is proud to announce its representation of Spartan Capital Securities, LLC in Janover Inc.'s initial public offering (IPO). Janover (Nasdaq: JNVR), a B2B fintech marketplace connecting commercial property borrowers and lenders, has closed its IPO, signaling a significant milestone for the company and its investors. Janover raised approximately $5.65 million in aggregate gross proceeds, with the underwriters' option potentially adding to the total. The offering closed on July 27, 2023.

The company sold 1,412,500 shares of common stock at a public offering price of $4.00 per share. This total gross proceeds were $5.65 million before accounting for any underwriting discounts, commissions, or other offering expenses.  Additionally, the underwriters have been granted a 45-day option to purchase up to an additional 211,875 shares of common stock at the initial public offering price, allowing them to cover any over-allotments that may arise during the offering process. 

In connection with the IPO, Janover has listed its common stock on the Nasdaq Capital Market. Trading under the symbol "JNVR" commenced July 25, 2023. This listing marks a significant moment in Janover's journey as a publicly traded company, opening up new opportunities for growth, visibility, and access to capital markets.

Janover has strategically planned the allocation of net proceeds from the IPO to support its long-term goals and enhance its position within the fintech marketplace. A substantial portion of the net proceeds will be channeled towards the development of new products and the improvement of existing offerings. This investment aims to bolster the company's ability to meet the evolving needs of commercial property borrowers and lenders effectively.  Janover intends to allocate funds to expand its sales and marketing capabilities. A robust marketing strategy will enable the company to increase brand awareness, attract more users to its platform, and foster strategic partnerships within the industry.  The remaining proceeds will be utilized for general corporate purposes, including capital expenditures and working capital. These funds will play a crucial role in supporting day-to-day operations and ensuring the company's ongoing stability and growth.

Spartan Capital Securities, LLC, and R.F. Lafferty & Co., Inc. served as joint book-running managers.  Lucosky Brookman had the privilege of representing Spartan Capital Securities, LLC.

We are delighted to announce that our client, Chardan Capital Markets LLC, has successfully facilitated a capital raise of $2.25 million for Sonnet BioTherapeutics Holdings, Inc. in an overnight registered direct offering and concurrent private placement.

The collaborative efforts of our attorneys and all parties were instrumental in steering this transaction to a successful close.  The transaction involved the purchase and sale of an aggregate of 5,000,000 shares of Sonnet's common stock (or common stock equivalents), at a purchase price of $0.45 per share of common stock (or common stock equivalent). It also included issuing warrants for the investor to purchase up to an aggregate of 5,000,000 shares of common stock. The warrants will be exercisable six months from issuance and will expire three and one-half years from the issuance date. 

Our role in this transaction underscores our ongoing commitment to our clients and our ability to successfully navigate complex deals.  We extend our congratulations to Chardan and Sonnet on this significant achievement. This success is a testament to the hard work and persistence of the teams at both Chardan, Sonnet and our law firm, emphasizing our shared commitment to excellence.

We are proud to announce that our client, American Rebel Holdings, Inc., has successfully raised $3.0 million through a private placement. The company, known for its distinctively branded safes, personal security, self-defense products, and branded apparel, has effectively navigated the transaction process. 

Our team worked hand-in-hand with the exclusive placement agent for the offering, EF Hutton, a division of Benchmark Investments, LLC. Our joint efforts ensured the process unfolded smoothly, effectively, and in the best interests of our client.

Congratulations to our client, EF Hutton, a division of Benchmark Investments, LLC, in its role as the sole underwriter and bookrunner, for pricing the public offering of securities for Security Matters (SMX) PLC.

This offering was crafted with the aim of procuring gross proceeds of approximately $3.2 million, prior to the deduction of underwriting discounts, commissions, and offering expenses. The offering comprises 13,333,333 ordinary shares of SMX, each with a par value of $0.0001, alongside an equivalent number of Warrant A and Warrant B, each providing the option to subscribe to ordinary shares at an exercise price of $0.24 per share.

We are excited to announce that our client, EF Hutton, a division of Benchmark Investments, LLC, has successfully closed the underwritten public offering on behalf of Bone Biologics Corporation (NASDAQ: BBLG). This transaction is a testament to the relentless dedication and tireless work of all parties involved, especially the efforts of our exemplary legal team in collaboration with EF Hutton.

Lucosky Brookman is pleased to congratulate its client, Recruiter.com Group, Inc. (NASDAQ: RCRT)(NASDAQ: RCRTW), on the signing of a definitive agreement for the planned purchase of the fintech assets of GoLogiq, Inc. (OTC:GOLQ). GoLogiq, a prominent U.S.-based global provider of fintech and consumer data analytics, will contribute valuable resources and expertise to enhance Recruiter.com's portfolio of recruiting solutions.

Lucosky Brookman LLP, a leading law firm specializing in corporate finance and securities law, is pleased to congratulate its client, Titan Partners Group, a division of American Capital Partners, LLC, on the successful completion of a $4 million registered direct offering of CISO Global Inc. (NASDAQ: CISO) ("CISO" or the "Company"). CISO is an industry leader in managed cybersecurity and compliance solutions, headquartered in Scottsdale, Arizona.

Lucosky Brookman LLP, a renowned law firm specializing in corporate finance and securities law, is proud to extend its heartfelt congratulations to its client Modular Medical, Inc. (Nasdaq: MODD), on the successful pricing of its upsized underwritten public offering. Modular Medical, a development stage insulin delivery technology company, aims to revolutionize the market by introducing the next generation of easy-to-use and affordable insulin pump technology.

Lucosky Brookman is proud to have supported its client, HeartBeam Inc., a cardiac technology company, in successfully closing a secondary offering of 16,666,666 shares of common stock. This $25 million financing will enable HeartBeam to fund key clinical and regulatory milestones for its innovative 3D-vector electrocardiogram (VECG) platform, HeartBeam AIMIGo™, and prepare for its commercial launch in 2024.

Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to U Power Limited ("U Power" or the "Company"), a company focused on commercializing battery swapping and compatible electric vehicles, in pricing of its initial public offering of 2,500,000 shares of its common stock at a public offering price of $7.00 per share for a total of $17,500,000 of gross proceeds to the Company.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC (“EF Hutton), on its successful $4.0 million Private Placement for Reliance Global Group, Inc. (NASDAQ: RELI; RELIW) (the “Company”), an InsurTech pioneer which combines artificial intelligence (AI) and cloud-based technologies with the personalized experience of a traditional insurance agency.

Under the terms of the securities purchase agreement, the Company sold 155,038 shares of common stock and accompanying common warrants (the “Common Units”) and 897,594 pre-funded warrants and accompanying common warrants (the “Pre-Funded Units”) to purchase an aggregate of 2,105,264 shares of common stock underlying the common warrants. Each Common Unit was sold at a combined effective purchase price of $3.80 and the Pre-Funded Units were sold at the same price as the Common Units less the pre-funded warrant exercise price of $0.001. The common warrants will be exercisable six months from the date of issuance at an initial exercise price of $3.55 per share, subject to adjustments as set forth therein, and will expire five and a half years from the date of issuance.

The Company intends to use the net proceeds from the private placement for general working capital and administrative purposes.

EF Hutton acted as exclusive placement agent for the offering.   Lucosky Brookman acted as legal counsel to EF Hutton.

Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to Mangoceuticals, Inc. ("MangoRx" or the "Company"), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, in pricing of its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share for a total of $5,000,000 of gross proceeds to the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of its common stock at the public offering price of $4.00 per share, less the underwriting discounts and commissions, to cover over-allotments, if any.

Lucosky Brookman LLP provided strategic and legal guidance to Mangoceuticals, enabling the company to achieve success in the IPO. The firm's seasoned securities lawyers have in-depth knowledge and experience in dealing with the legal and regulatory requirements associated with going public. They worked closely with Mangoceuticals throughout the IPO process to help the company meet NASDAQ's stringent listing standards and compliance requirements, which were vital to the success of the offering.

Lucosky Brookman LLP played a pivotal role in advising the company on the nuances of NASDAQ's rules and regulations, the preparation of the prospectus, and the filing of the registration statement. They were also instrumental in providing guidance to the company on the preparation of its governance and compliance policies, which are essential to maintaining the company's status as a publicly traded entity.

Lucosky Brookman LLP congratulates Mangoceuticals on its successful IPO and looks forward to continuing its work with the company in achieving its strategic goals. The firm's seasoned securities lawyers are committed to providing clients with strategic and legal guidance to navigate the complexities of the capital markets. They have the experience and knowledge necessary to provide clients with tailored solutions that meet their unique business objectives.

Lucosky Brookman is proud to congratulate their client, SOBR, on their successful partnership with Aegis Capital Corp. As a trusted legal advisor to SOBR, Lucosky Brookman is thrilled to have played a key role in this exciting achievement.

SOBR, a leading provider of technology-enabled alcohol monitoring devices, has announced that Aegis Capital Corp acted as its exclusive placement agent for a $3.5 million financing round. The financing will be used to support the growth of SOBR's cutting-edge alcohol monitoring technology and expand their presence in the market.

Lucosky Brookman congratulates its client, Clean Vision Corporation (OTCQB: CLNV) (“Clean Vision” or the “Company”), an emerging leader in the sustainable clean technology and green energy sectors, in its $4 million dollar financing round that closed on February 23, 2023, which will allow the Company to rapidly execute on its business model supporting a portfolio of sustainable ventures targeting key environmental challenges.

Lucosky Brookman announced today that it successfully represented its client, Unique Logistics International, Inc. (OTC Markets: UNQL), in the acquisition of operating subsidiaries and affiliates of the former parent company. The acquisition involved purchasing all the share capital in ten subsidiaries and affiliates from Unique Logistics Holdings Limited, a Hong Kong corporation, and Frangipani Trade Services, Inc., a United States corporation.

The acquired companies are based in China, Hong Kong, India, Taiwan, the United Kingdom, and Vietnam, and are all specialist logistics companies in their respective countries of operation. With this acquisition, UNQL is expected to increase its logistics services in the countries of the acquired companies, exports from the United States to those countries, and trade among the countries of the acquired companies and Europe, Latin America, Canada, and Intra-Asia.

Lucosky Brookman acted as corporate counsel to Unique Logistics International during this transaction. The acquisition is anticipated to significantly increase UNQL's footprint, providing direct management control of 30 offices in 5 countries, including the United States, and 9 additional offices managed through affiliates that are not majority-owned. The customer base acquired through the acquisition is expected to increase revenue by 40% on consolidation.

Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to Lucy Scientific Discovery, Inc. in connection with the successful completion of the company's recent initial public offering (IPO). Lucy Scientific Discovery is a clinical-stage biotechnology company committed to developing innovative gene therapies. The company offered 7,500,000 shares of common stock at a public offering price of $10.00 per share, raising gross proceeds of $75 million before underwriting discounts, commissions, and other expenses. The offering closed on February 13, 2023, and the underwriters have a 45-day option to purchase up to an additional 1,125,000 shares of common stock from Lucy Scientific Discovery.

Lucosky Brookman LLP congratulates its clients Chardan Capital Markets LLC in closing the offering of 13,888,888 shares of common stock and investor warrants to purchase up to an aggregate of 27,777,776 shares of common stock. Each share of common stock was sold together with one investor warrant to purchase two shares of common stock at a combined offering price of $1.08, for total gross proceeds of approximately $15.0 million.

Lucosky Brookman LLP congratulates its client, Grom Social Enterprises, Inc. (NASDAQ: GROM) (the “Company”), a media, technology and entertainment company dedicated to family-friendly programming, web filtering technology and safe social media for kids, for closing a private placement transaction with a single institutional investor and raising gross proceeds of approximately $3.0 million.  The Company issues 1,327,434 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase 2,323,010 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold together with accompanying warrants at a combined effective purchase price of $2.26 priced at-the-market under Nasdaq rules. The pre-funded units were sold at the same price less the pre-funded warrant exercise price of $0.01. The warrants will be immediately exercisable from the date of issuance at an initial exercise price of $2.26 per share, subject to adjustments as set forth therein, and will expire five years from the date of issuance.

Lucosky Brookman LLP acted as a counsel to the Company, while EF Hutton, division of Benchmark Investments, LLC, acted as exclusive placement agent for the offering.

Lucosky Brookman LLP congratulates its client Unique Logistics International, Inc.  (NASDAQ: UNQL), a global logistics and freight forwarding company, on entering into a definitive agreement and plan of merger with Edify Acquisition Corp (NASDAQ: EAC) (“Edify”), a special purpose acquisition company, for a proposed business combination of the two companies. Under the Merger Agreement, subject to satisfaction of the closing conditions contained therein, Unique will merge with a subsidiary of Edify, and thereby become a wholly-owned subsidiary of Edify. Upon completion of the merger, class A common stock of the combined company will be listed on the Nasdaq Capital Market.

Lucosky Brookman LLP congratulates its client, Adamas One Corp. (NASDAQ: JEWL) (the “Company”), The Original Lab-Grown Diamond Company ™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, in the pricing of its underwritten initial public offering of 2,450,000 shares of common stock at an initial public offering price of $4.50 per share for gross proceeds of $12,000,000, before underwriting discounts and commissions and estimated offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to 367,000 additional shares of common stock at the offering price, less the underwriting discount.

Lucosky Brookman LLP congratulates its client Chardan Capital Markets LLC for its invaluable work closing the business combination between Pacifico Acquisition Corp. (NASDAQ: PAFOU, “Pacifico,” or the “Company”), a special purpose acquisition company, and Caravelle Group Co., Ltd ("Caravelle"), a global ocean technology company. The business combination was approved by Pacifico’s shareholders on November 30, 2022. Upon completion of the cusiness combination, Caravelle International Group, the combined company, became a publicly traded entity. The combined company’s ordinary shares commenced trading on the Nasdaq Capital Market under the symbol "CACO" on December 19, 2022.

Lucosky Brookman congratulates its client, The Flexi Group, one of APAC’s Largest Operators of Flexible Workspaces, on going public through a merger with Tsangs Group’s TG Venture Acquisition Corp.

The Flexi Group manages 45 locations in 12 cities and 9 countries in Asia and Australia under regionally recognized brands the Hive, Common Ground and The Cluster. Combination values The Flexi Group at an implied pro forma enterprise value of $205 million.

 After closing, The Flexi Group's ordinary shares are expected to trade on the Nasdaq Stock Market LLC under the ticker symbol FLXG.

ARC Group Limited is serving as exclusive financial advisor to The Flexi Group with Lucosky Brookman LLP serving as legal counsel to The Flexi Group.  

Lucosky Brookman congratulates its client, My Job Matcher, Inc, an AI-enabled technology recruitment platform, on securing an undisclosed investment from two New York- and California-based financial institutions, Serengeti Asset Management and Ghost Tree Partners. This investment will accelerate the delivery and development of Job.com’s technology and fund further acquisitions in the recruitment and staffing sector.

Lucosky Brookman LLP congratulates its client Chardan Capital Markets LLC which served as M&A and capital advisor in connection with a definitive merger agreement by and between WaveTech Group (Nasdaq: WTG), technology company specializing in next-generation battery-enhancing technologies, and Welsbach Technology Metals Acquisition.  The combined entity had a pro forma enterprise value of $228 million.

Lucosky Brookman congratulates its client, Bloomios, Inc. (the “Company”) (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, on its acquisition of Infusionz, a wholly-owned subsidiary of Upexi (NASDAQ: UPXI). The acquisition includes Infusionz's portfolio of CBD gummy brands and customers, along with its associated order flow, product formulations, manufacturing operations, equipment and sales team. 

Lucosky Brookman LLP congratulates its client, TenX Keane Acquisition (NASDAQ: TENK; TENKU) (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company formed for the purpose of effecting a merger, in its initial public offering of 6,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one ordinary share and one right. Each right entitles the holder thereof to receive two-tenths (2/10) of one ordinary share upon consummation of the Company’s initial business combination. The units began to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “TENKU” on October 14, 2022.

Lucosky Brookman LLP congratulates its client, Castellum, Inc. (NYSE: CTM) (the “Company”), a cybersecurity, electronic warfare, and IT services company, in its public offering of common stock at a public offering price of $2.00 per share. Castellum sold 1,500,000 shares of its common stock and granted the underwriters a 45-day option to purchase up to an additional 225,000 shares of common stock at the public offering price less the underwriting discounts and commissions, to cover over-allotments. The shares began trading on the NYSE American Exchange on October 13, 2022, under the ticker symbol “CTM”.

Lucosky Brookman LLP congratulates its client, Laser Photonics Corporation (NASDAQ: LASE) (the “Company”) a leading global industrial developer of high-tech laser systems for laser cleaning, and other materials applications, in pricing of its initial public offering of 3,000,000 shares of common stock at a price to the public of $5.00 per share for gross proceeds of $15.0 million. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 450,000 shares of its common stock. The Company expects to use the net proceeds of $13.8 million for general corporate purposes, including growth investments, and potential acquisitions.

Lucosky Brookman LLP congratulates its client, Connexa Sports Technologies, Inc. (NASDAQ: CNXA) on the closing of its $5 Million private placement transaction. 12,820,512 shares of common stock were sold in the offering, together with 12,820,512 warrants at an exercise price of $0.39 per share and 25,641,024 warrants at an exercise price of $0.43 per share. Connexa intends to use the net proceeds from the offering for working capital purposes and to repurchase inventory.

Lucosky Brookman LLP congratulates its client, SOBR Safe, Inc. (NASDAQ: SOBR), providers of industry-leading alcohol screening solutions, in the closing of its $6 Million private placement with multiple institutional investors.

Lucosky Brookman LLP congratulates its client, Avanseus Holdings, Inc., on its business combination with Fat Projects Acquisition.

Avanseus Holdings Pte. Ltd. and Fat Projects Acquisition, both based in Singapore, executed a business combination agreement that would give Avanseus a pro forma enterprise value of approximately $135.7 million.

Avanseus specializes in building enterprise solutions driven by analytics, artificial intelligence, machine learning, and cognitive computing. It has developed a suite of artificial intelligence-based proprietary algorithms that continuously analyze relevant data and is currently focused on predictive operations and maintenance software, primarily in the telecommunications sector. Avanseus solutions are deployed in Asia, the United Kingdom, Europe, and South America.

Avanseus was founded in 2015 and is headquartered in Singapore, with employees based in Singapore, India, and Italy, and a network of partners across key global markets.

Lucosky Brookman served as U.S. legal counsel to Avanseus

Lucosky Brookman LLP congratulates its client, Digerati Technologies, Inc. (OTCQB: DTGI), a Hispanic-led and founded provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business market, on the execution of a Business Combination Agreement pursuant to which it shall list on NASDAQ via a transaction with Minority Equality Opportunities Acquisition Inc (MEOA). 

Lucosky Brookman LLP congratulates its client, Mill City Ventures III, Ltd. (NASDAQ:MCVT), a non-bank lender and specialty finance company, on its successful pricing of its underwritten public offering of 1,250,000 shares of common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of $5,000,000, before underwriting discounts and commissions. In addition, the Company has granted the underwriters a 45-day option to purchase up to 187,500 additional shares of common stock at the offering price, less the underwriting discount. Concurrent with the offering, the Company commenced trading on the Nasdaq Capital Market.

Lucosky Brookman congratulates its client, Spartan Capital on its successful $6.58 million underwritten public offering of Nocera, Inc. (NASDAQ: NCRA), a fully integrated sustainable seafood company with a focus on manufacturing and operating land-based Recirculatory Aquaculture Systems (RAS). Concurrently with the offering, the Company listed its shares on NASDAQ.  

The Company closed on its underwritten public offering of 1,880,000 units, each unit consisted of one share of common stock and one warrant to purchase two shares of Common Stock, at a public offering price of $3.50 per unit, for aggregate gross proceeds of $6.58 million, prior to deducting underwriting discounts, commissions, and other estimated offering expenses. 

Each Warrant permits the holder to purchase two shares of common stock at an exercise price of $3.85 (110% of the per unit offering price) and expires five years after the date of issuance. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 282,000 units at the public offering price per unit, less the underwriting discounts and commissions, to cover over-allotments, if any.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful upsized $11.7 million public offering and NYSE American Listing of Graphex Group Limited (NYSE American: GRFX), global leader in mid-stream processing of specialized natural graphite used for electric vehicle (EV) lithium-ion (Li-ion) batteries. The Company closed on the upsized public offering of 4,695,653 American Depositary Shares (ADSs), each ADS representing 20 ordinary shares, par value HK$0.01 per share, of the Company, at a public offering price of $2.50 per ADS, for aggregate gross proceeds of approximately $11.7 million before deducting underwriting discounts, commissions, and other offering expenses. In addition, Graphex has granted the underwriters a 45-day option to purchase up to an additional 704,347 ADSs at the public offering price per ADS, less the underwriting discounts and commissions, to cover over-allotments, if any.

Lucosky Brookman congratulates its client, Job.com, the data-driven, AI-powered recruitment platform, on acquiring PrincetonOne, a New Jersey-based talent solutions provider with an emphasis on Recruitment Process Outsourcing (RPO) and permanent recruitment services. The acquisition is a continuation of Job.com’s strategic plan to develop revenue and reach by acquiring successful businesses and supporting intelligent growth with the application of Job.com’s proprietary technology. Each acquisition provides an opportunity for the AI to continue learning from new data and subsequently delivers a more effective and efficient hiring process for recruiters and job seekers alike.

Lucosky Brookman congratulates its client, Brüush Oral Carel, Inc. (Nasdaq:BRSH) (the “Company”), on the pricing of its initial public offering of 3,728,549 units at a combined public offering price of $4.16 per unit, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an initial exercise price of $4.16 per share. The gross proceeds of the offering are expected to be $15.5 million before deducting underwriting fees and other estimated offering expenses. The offering is expected to close on or about August 5, 2022, subject to customary closing conditions. In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase additional shares of common stock and/or warrants of up to 15% of the number of shares and warrants, respectively, sold in the offering solely to cover over-allotments, if any.

Lucosky Brookman congratulates its client, a leading Georgia-based gaming company, on the successful closing of its $120 million senior secured loan facility.  Fortress Investment Group LLC, a highly diversified global investment manager with approximately $53.3 billion of assets under management, advanced the funds to the company, along with a syndicate of other lenders.  The firm represented the company and assisted with the drafting, reviewing, revising and structuring the senior secured credit facility.  $120,000,000 of the proceeds were utilized by the company to refinance an existing facility with the balance to be used by the company to finance acquisitions to grow its business.

Lucosky Brookman congratulates its client American Rebel Holdings, Inc. (NASDAQ: AREB) (NASDAQ: AREBW) (the “Company”), a designer and marketer of branded safes and personal security, and self-defense products, on a successful closing of its private placement of common stock (or pre-funded warrants in lieu thereof) and warrants.

Lucosky Brookman congratulates its client, Brain Scientific, (OTCQB: BRSF) (the "Company"), a medical technology company with multiple patents and FDA-cleared products, on its successful private placement of $5.6 million of senior secured convertible debentures and warrants, and converting approximately $12.9 million of existing debt into equity.

Lucosky Brookman LLP congratulates its client, Connexa Sports Technologies Inc. (NASDAQ: CNXA), on offering of $4.2 million of its common stock and uplisting onto the NASDAQ Capital Market.

In conjunction with the NASDAQ listing, Connexa sold 1,048,750 million shares of its common stock at $4.00 per share for gross proceeds of $4.2 million, before deducting underwriting discounts and commissions and other offering expenses. Connexa has granted the underwriters a 45-day option to purchase up to 150,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions to cover overallotments. The shares sold consisted of one million primary shares of common stock and 48,750 shares from the underwriters’ partial exercise of their overallotment option. Connexa plans to use the funds raised for working capital, debt reduction and general corporate purposes. The offering closed on June 17, 2022.

The Company's common stock began trading on the NASDAQ Capital Market on June 16, 2022, under the symbol "CNXA".

“Uplisting to the Nasdaq is the next step in our evolution as a public company, particularly after our acquisitions of PlaySight, Gameface.AI and Foundation Tennis,” said Mike Ballardie, Connexa CEO. “For us to come this far after only beginning operations two years ago is a tremendous feat and a testament to our dedicated employees, partners, products and customers that have enabled this milestone.”

Lucosky Brookman LLP acted as counsel to the Company.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $16.5 million registered direct offering of Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) ("Odyssey Marine Exploration" or "Company"), a global subsea mineral exploration and development company. Under the terms of the subscription agreements, the Company has agreed to sell approximately 4.9 million units (“Units”). Each Unit consists of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and one warrant to purchase one share of Common Stock (the “Warrant”). The Warrants are exercisable at any time beginning six months after the date of issuance and ending on the fifth anniversary of issuance. The Warrants have an exercise price of $3.35 per share. The purchase price for each Unit is $3.35. 

The gross proceeds to the Company from the registered direct offering are approximately $16.5 million, before deducting the placement agent’s fees and other estimated offering expenses. The Company intends to use the net proceeds from the offering for debt reduction and general corporate purposes. 

Lucosky Brookman represented EF Hutton in its capacity as sole book-running manager.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $4 million underwritten public offering of American Depositary Shares (ADS) of TC Biopharm (Holdings) PLC (Nasdaq: TCBP; TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications. The offering  consists of 10,000,000 ADSs, each ADS representing one ordinary share of the Company, at a public offering price of $0.40 per ADS, for aggregate gross proceeds of $4 million, prior to deducting underwriting discounts and commissions, and other offering expenses.  In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 1.5 million ADSs at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments, if any. 

Lucosky Brookman represented EF Hutton in its capacity as sole book-running manager.

Lucosky Brookman LLP congratulates SOBR Safe, Inc. (NASDAQ: SOBR), providers of innovative solutions for alcohol policy management, on its successful pricing of its underwritten public offering of 2,352,942 units (the “Common Units”), at a price to the public of $4.25 per Common Unit, for aggregate gross proceeds of $10 million, prior to deducting underwriting discounts, commissions, and other estimated offering expenses. Each unit consists of one share of common stock, par value $0.00001 per share, and two warrants, each warrant exercisable for one share of common stock. The common stock and warrants are immediately separable from the Units and will be issued separately. The warrants are exercisable immediately, expire five years from the date of issuance and have an exercise price of $4.25.

The Company also announced that, in connection with the offering, its common stock has been approved for listing on the Nasdaq Capital Market and began trading on the Nasdaq Capital Market under the symbol "SOBR" on May 16, 2022.

Joseph Lucosky, Managing Partner of Lucosky Brookman, commented, “No transaction is easy and this one was no exception given the tremendous market obstacles. Congratulations to CEO, Dave Gandini, all the bankers Aegis Capital Corp. and the attorneys at Lucosky Brookman who Lucosky Brookman acted as counsel to Aegis Capital Corp., the lead book-running manager for the offering.

Lucosky Brookman LLP congratulates its client, Modular Medical, Inc. (NASDAQ: MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, on its closing of registered direct offering of an aggregate of 449,438 shares of its common stock at an offering price of $4.45 per share, and, in lieu of common stock, pre-funded warrants to purchase up to 1,348,314 shares of common stock at an offering price of $4.44 per pre-funded warrant, which represents the per share offering price for the common stock less the $0.01 per share exercise price for each pre-funded warrant. Concurrent with the registered direct offering, the Company has also agreed to issue to the Investor unregistered common stock purchase warrants (the "Private Placement Warrants") to purchase up to 1,438,202 shares of common stock in a private placement. The Private Placement Warrants have an exercise price of $6.60 per share and are exercisable beginning six months from the date of issuance for a period of five years. The gross proceeds from the registered direct offering and concurrent private placement are expected to be $8 million before deducting placement agent fees and other estimated offering expenses. 

Lucosky Brookman LLP congratulates its client, Vivakor, Inc. (NASDAQ: VIVK), a socially responsible operator, acquirer and developer of clean energy technologies and environmental solutions, on the successful closing of its underwritten public offering of 1,600,000 shares of common stock (the "Common Stock"), at a public offering price of $5.00 per share, for aggregate gross proceeds of $8.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 240,000 shares of Common Stock at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments, if any.

Lucosky Brookman LLP congratulates its client, Modular Medical, Inc. (NASDAQ: MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, on its successful pricing of its underwritten public offering of 2,500,000 units at a price to the public of $6.00 per unit, for aggregate gross proceeds of $15 million, prior to deducting underwriting discounts, commissions and other estimated offering expenses. Each unit consists of one share of common stock, par value $0.001 per share, and one warrant to purchase one share of common stock. The common stock and warrants are immediately separable from the Units and will be issued separately. The warrants are exercisable immediately, expire five years from the date of issuance and have an exercise price of $6.60 per share.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $16.3 million initial public offering of TC Biopharm (Holdings) PLC (Nasdaq: TCBP; TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications. The offering consists of 3,823,530 American Depositary Shares (the “ADSs”) and warrants (the “Warrants”) to purchase up to 7,647,060 ADSs, for aggregate gross proceeds of approximately $16.3 million, prior to deducting underwriting discounts, commissions, and other offering expenses. Each ADS represents one ordinary share, and each Warrant represents the right to purchase one ADS. The ADSs and Warrants will be separately issued but the ADSs and Warrants will be sold to purchasers only in a combination of one ADS and two Warrants, for a combined aggregate offering price of $4.25. Each Warrant will be immediately exercisable for one ordinary share, that will then be deposited with the custodian for the issuance of a corresponding ADS at an exercise price of $4.25 per ADS and expire six years after the issuance date.

Lucosky Brookman LLP congratulates its client, American Rebel Holdings, Inc. (NASDAQ: AREB; AREBW), a designer and marketer of branded safes and personal security, and self-defense products, on its successful pricing of its underwritten public offering of 2,530,121 units (the “Common Units”), at a price to the public of $4.15 per Common Unit, for aggregate gross proceeds of approximately $10.5 million, prior to deducting underwriting discounts, commissions, and other estimated offering expenses. Each Common Unit consists of one share of common stock, par value $0.001 per share (the “Common Stock”), and one warrant to purchase one share of Common Stock (each a “Warrant” and collectively the “Warrants”). The Common Stock and Warrants are immediately separable from the Common Units and will be issued and traded separately. The Warrants are exercisable immediately, expire five years from the date of issuance and will have an exercise price of $5.1875 per share.

Lucosky Brookman LLP congratulates its client, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) on its successful closing of an underwritten public offering of 4,144,068 American Depositary Shares ("ADSs") at a public offering price of $2.36 per ADS for gross proceeds to the Company of approximately $9.8 million. BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

Lucosky Brookman congratulates its client, EF Hutton on its successful public offering of $8.0 million of common stock of Applied UV, Inc. (Nasdaq: AUVIP). Applied UV, Inc. is an industry leader in air and surface pathogen elimination technology. The Company announced the pricing of its underwritten public offering of 2,666,667 shares of common stock at a public offering price of $3.00 per share, for aggregate gross proceeds of approximately $8.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $287.5 million initial public offering of BurTech Acquisition Corp (Nasdaq: BRKHU). The offering  consists of 25,000,000 units at $10.00 per unit. Each unit consists of one share of Class A common stock and one redeemable warrant, with each warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. The underwriters exercised their over-allotment option in full for an additional 3,750,000 units on December 13, 2021, which closed at the time of the closing of the Offering. As a result, the aggregate gross proceeds of the Offering, including the over-allotment, are $287.5 million, prior to deducting underwriting discounts, commissions, and other Offering expenses.

Lucosky Brookman LLP congratulates its Australian client, Advanced Human Imaging Limited (ASX:AHI) (NASDAQ: AHI) on its successful closing of its U.S. initial public offering of 1,000,000 units at a price to the public of US$10.50 per unit. Each unit issued in the offering consists of two American Depositary Shares ("ADSs") and one warrant to purchase one ADS. Each ADS offered represents 7 ordinary shares of AHI. The warrants will be exercisable immediately, expire three years from the date of issuance and will have an exercise price of US$5.52 per ADS. The ADSs and warrants are immediately separable and will be issued separately. Gross proceeds from the offeringare US$10.5 million.

Lucosky Brookman LLP is pleased to share that its client GreenBox POS (Nasdaq: GBOX) (the “Company”), an emerging fintech company that leverages proprietary blockchain security and token technology to create customized payment solutions, closed on a $100 million indenture financing.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $100 million initial public offering of Energem Corp. (Nasdaq: ENCPU). The offering  consists of 10,000,000 units at $10.00 per unit. Each unit consists of one the Company’s Class A ordinary shares and one redeemable warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “ENCP” and “ENCPW,” respectively.

Lucosky Brookman LLP congratulates its client, Heartbeam, Inc. (Nasdaq: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, on its successful initial public offering of $16.5 million common stock and warrants. The company announced the pricing of its initial public offering of 2,750,000 units, each consisting of (i) one share of common stock and (ii) one warrant to purchase a share of common stock, at a public offering price per unit of $6.00. The warrants have an exercise price of $6.00 per share and are exercisable for a period of five years after the issuance date.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $13.0 million initial public offering of Healthcare Triangle, Inc. (Nasdaq: HCTI). Healthcare Triangle, Inc. announced the pricing of its initial public offering of 3,262,500 shares of common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $13.0 million.

Lucosky Brookman LLP congratulates its client, SurgePays, Inc. (Nasdaq: SURG) on its successful public offering of $19.8 million of common stock and warrants. The offering allowed the company to uplist from the OTCQB to NASDAQ. SurgePays, Inc. is a blockchain fintech company building a next generation supply chain network that offers cost-efficient, wholesale goods and financial services for the underbanked. The company announced the pricing of its underwritten public offering of 4,600,000 units at a price to the public of $4.30 per unit.

Lucosky Brookman LLP congratulates its client, Esports Entertainment Group (Nasdaq: GMBL), (Nasdaq: GMBLW) on its successful public offering of shares of preferred stock and capital raise of $8,000,000. The Company has commenced an underwritten registered public offering of its 10.0% Series A Cumulative Redeemable Convertible Preferred Stock, par value $0.001 per shares, at a price of $10.00 per share. Each share of Series A Preferred Stock will be convertible into shares of the Company’s common stock, at a conversion price of $17.50 per common share, at any time at the option of the holder. In connection with this offering, the Company expects to grant the underwriters a 45-day option to purchase additional shares of Series A Preferred Stock at the public offering price, less underwriting discounts and commissions.

Lucosky Brookman congratulates its client, Job.com on acquiring Fortus Healthcare Resources and Endevis, adding $50 Million of annual revenue. Lucosky Brookman assisted the Company with the Fortus Healthcare Resources acquisition, a company which specializes in the direct and travel placement of healthcare professionals with an emphasis on nursing. The Firm previously worked with Job.com on the Acquisition of HireVergence.

Lucosky Brookman congratulates its client, Slinger Bag, Inc. (OTCQB: SLBG), on successfully completing its $11 million private placement offering. Slinger Bag, Inc. is a leading sports brand focused on innovating game improvement technology and equipment. Participating investors in this funding round include several leading small-cap focused investment funds, as well as several high-net-worth individual investors.

Lucosky Brookman LLP congratulates its client, Maxim Group LLC on its successful public offering of $18 Million of Worksport Ltd. (Nasdaq-CM: WKSP; WKSPW) common stock and warrants. The offering allowed the company to uplist from the OTCQB to NASDAQ.  Lucosky Brookman represented Maxim Group in its capacity as underwriter and sole book-running manager.

Lucosky Brookman LLP is pleased to share that on June 30, 2021, its client Recruiter.com Group, Inc. (OTCQB: RCRT), an on-demand recruiting platform, closed its public offering of 2.4M units at $5.00 per unit. Each unit consists of one common share and one warrant to purchase one common share. Lucosky Brookman acted as corporate and securities counsel to the Company.

Lucosky Brookman LLP is pleased to share that on June 29, 2021, its client NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), announced that it has closed a registered direct offering of 7,500,000 shares of the Company’s common stock for gross proceeds of $3,000,000 pursuant to an effective shelf registration statement on Form S-3. Lucosky Brookman acted as corporate and securities counsel to the Company.

Lucosky Brookman LLP congratulates its client EF Hutton, a division of Benchmark Investments, LLC, on its successful $6.0 Million Underwritten Public Offering of common stock of Global Self Storage, Inc. (NASDAQ: SELF). EF Hutton acted as underwriter and the sole book-running manager for the offering.

Lucosky Brookman LLP is pleased to share that on June 21, 2021, its client Creatd Inc. (Nasdaq CM: CRTD), closed its underwritten public offering of 750,000 shares of its common stock, at a public offering price of $3.40 per share, for a total offering size of approximately $2.6 million. Lucosky Brookman acted as corporate and securities legal counsel to the Company.

Lucosky Brookman LLP is pleased to share that on June 03, 2021, its client LifeMd, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, successfully closed a $15 million debt financing with B. Riley Principal Investments. Lucosky Brookman acted as corporate and securities legal counsel to the Company.

Lucosky Brookman LLP is pleased to share that on July 7, 2021 its client, Joseph Gunnar & Co. LLC, successfully served as underwriter in connection with the private placement of $8.88 Million of securities of Sysorex, Inc. (OTCQB: SYSX), a U.S.-based, publicly-traded Ethereum mining and blockchain technologies company.  In connection with the offering, accredited investors purchased 12.5% Original Issue Discount Senior Secured Convertible Debentures in an aggregate principal amount of $8,880,000 and Warrants to purchase up to 3,534,751 shares of the Company’s common stock.

Lucosky Brookman LLP is pleased to announce that its client Esports Entertainment Group, Inc. (NASDAQ: GMBL), successfully closed its acquisition of Helix eSports LLC and ggCircuit LLC.  The purchase price was approximately $45 Million.  The Firm acted as corporate, securities and M&A counsel to the company. 

Lucosky Brookman LLP is pleased to share that on May 27, 2021 its client Ammo, Inc., (NASDAQ: POWW) consummated a firm commitment public offering of 138,220 newly issued shares of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock at a public offering price of $25.00 per share.  Lucosky Brookman acted as corporate and securities legal counsel to the Company.

Lucosky Brookman LLP is pleased to announce that its client Creatd, Inc. (NASDAQ: CRTD) entered into a securities purchase agreement with three accredited investors (the “Investors”), whereby, at the closing, the Investors have agreed to purchase from the Company (i) convertible notes in the aggregate principal amount of $4,666,668, inclusive of original issuance discount, and (ii) 1,090,908 warrants to purchase shares of the Company’s common stock. The Notes are convertible into shares of Common Stock at a fixed price of $5.00 per share, subject to adjustment as set forth in the Notes. Creatd, Inc. received $4.0 million of gross proceeds, reflecting an original issuance discount of $666,668.

NASDAQ-listed ammunition and munition components manufacturer in the $240 Million acquisition of the world’s largest on-line auction marketplace dedicated to firearms, hunting, shooting and related products.

Lucosky Brookman LLP represented Integrated Ventures, Inc. in the Closing of $9.0 Million Registered Direct Offering.  Integrated Ventures, Inc. (OTC; INTV) has entered into a securities purchase agreement with certain institutional investors to purchase $9.0 million worth of its common stock and warrants in a registered direct offering.  Under the terms of the securities purchase agreement, the Company has agreed to sell 30 million shares of its common stock and warrants to purchase approximately 30 million shares of common stock.  Lucosky Brookman acted as corporate and securities legal counsel to the company.  Kingswood Capital Markets, division of Benchmark Investments, Inc. acted as exclusive placement agent for  the offering.

Lucosky Brookman represented underwriter EF Hutton in $17 Million Public Offering of SPAC IMAC Holdings, Inc Common Shares. IMAC intends to use the net proceeds from the proposed offering to finance acquisitions of medical clinics, repay outstanding promissory notes, fund the launch of retail healthcare clinics, and for working capital and general corporate purposes. Lucosky Brookman LLP represented Kingswood Capital Markets who acted as sole bookrunning manager for the offering.

Lucosky Brookman represents client AMMO, Inc (NASDAQ: POWW) in their closing of $115 Million Underwritten Public Offering.  Ammo closed an underwritten offering of its common stock at a price of $5.00 per share, raising an aggregate amount of approximately $115 Million.  Ammo designs and manufactures products for law enforcement, military, sport shooting and self-defense.   Lucosky Brookman acted as corporate and securities legal counsel to the company.  Roth Capital Partners LLC and Alexander Capital L.P. acted as co-lead underwriters.

Lucosky Brookman represents Client Esports Entertainment Group, Inc. in its closing of $30 Million Acquisition of Lucky Dino Gaming Limited.  Esports has completed its acquisition of the business assets of Lucky Dino Gaming Limited ("Lucky Dino"), an established Malta licensed online casino operator with its own proprietary casino platform. The $30 Million deal was financed through cash raised in an equity offering in February.  Lucosky Brookman acted as corporate and securities legal counsel to the Company.

Lucosky Brookman represents client GreenBox POS in the closing of $50.1 Million Public Offering and Uplist to Nadsdaq.  GreenBox closed its underwritten public offering of 4,772,500 shares of common stock at a public offering price of $10.50 per share, which included the full exercise of the underwriter's over-allotment option for 622,500 shares of common stock, for gross proceeds to the Company of $50,111,250.   Lucosky Brookman acted as corporate and securities legal counsel to the Company.  Kingswood Capital Markets, division of Benchmark Investments, Inc., acted as sole bookrunning manager for the offering.

Lucosky Brookman represents client Esports Entertainment Group, Inc. (NASDAQ: GMBL) (NASDAQ: GMBLW) in the closing of $30 Million Registered Direct Offering.  Esports Entertainment Group, Inc., an esports entertainment and online gambling company, has closed its previously announced registered direct offering of 2,000,000 shares of its common stock at a price of $15.00 per share, for aggregate gross proceeds of $30 million, priced at-the-market under Nasdaq rules.  Lucosky Brookman acted as corporate and securities legal counsel to the Company.  Maxim Group LLC and Joseph Gunnar & Co., LLC acted as co-placement agents for the offering.

Lucosky Brookman represented underwriter EF Hutton in $100 Million Initial Public Offering of SPAC American Acquisition Opportunity, Inc. Common Shares. The company is a Special Purpose Acquisition Company (SPAC) formed for the purpose of effecting a merger, capital stock, exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.   Lucosky Brookman acted as corporate and securities legal counsel to the Company.  Kingswood Capital Markets, division of Benchmark Investments, Inc. acted as the sole book running manager for the offering.

Lucosky Brookman LLP represents Underwriter Maxim Group LLC in the Closing of $10.3 Million Offering with GeoVax Labs, Inc.  GeoVax Labs, Inc,  (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, closed its offering of 1,644,000 shares of its common stock, which included 204,000 shares sold pursuant to the full exercise of the underwriter’s option to purchase additional shares, at a price to the public of $6.25.  The gross proceeds from the offering were approximately $10.3 million.  Lucosky Brookman assisted its client, Maxim Group LLC, as underwriter’s counsel.  Maxim Group acted as the sole book-running manager in connection with the offering.

Lucosky Brookman LLP represents client, AMMO, Inc. (NASDAQ: POWW), a premier American ammunition and munition components manufacturer and technology leader, in the closing of its underwritten public offering of 8,564,285 shares of common stock at a price to the public of $2.10 per share, raising $18 Million. Lucosky Brookman served as the Company’s legal counsel in connection with the Offering and listing of its shares on to the NASDAQ Capital Market.

Lucosky Brookman counseled its client, Digerati Technologies, Inc. (OTCQB: DTGI), a provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business market, and its subsidiary T3 Communications, Inc., in connection with a $20 Million Senior Secured Credit Facility with Connecticut-based Post Road Group. The initial funding of $14 Million from the $20 Million multi-draw facility was used to close the Company’s acquisitions of Nexogy, Inc. (Nexogy.com) and ActivePBX (ActivePBX.com), and refinance existing debt. Lucosky Brookman served as counsel to the Company in connection with the $20 Million financing and both the asset acquisition and the share acquisition.

Lucosky Brookman represented its client, Conversion Labs, Inc., a direct-to-consumer telemedicine and wellness company, in connection with a $16 Million private placement with institutional investors. BTIG, LLC acted as exclusive placement agent for the offering. Conversion Labs CEO, Justin Schreiber states, “We are very excited to have closed this offering in expedited fashion and would like to thank our securities counsel in Lucosky Brookman whose leadership and strategic guidance has been an integral part of the Company now standing on the precipice of listing on a national exchange.”

Lucosky Brookman served as lead counsel to Siyata Mobile Inc. (TSX-V: SIM) (FRA: WK3D) (NASDAQ: SYTA, SYTAW) in closing its U.S. initial public offering of 2,100,000 units at a price of $6.00 per Unit. The Common Shares of the Company and Warrants were approved to list on the NASDAQ Capital Market under the symbols “SYTA” and “SYTAW,” respectively, and began trading on September 25, 2020. Siyata received gross proceeds of approximately $12.6 Million, before deducting underwriting discounts and commissions and other estimated Offering expenses. Psagot Investment House was the lead investor in the Offering. Psagot Investment House is an Israeli investment firm and the country's largest pension fund manager. Controlled by Apax Partners since 2010, the Firm manages assets and capital totaling US$40 billion.

Lucosky Brookman acted as lead counsel to Esports Entertainment Group, Inc. (NasdaqCM: GMBL) in connection with its successful uplist to the NASDAQ Capital Market and the pricing of its public offering of 1,980,000 units at a price to the public of $4.25 per unit. Maxim Group LLC acted as the lead book-running manager for the offering. Joseph Gunnar & Co., LLC acted as co-book-running-manager for the offering.

Lucosky Brookman acted as lead counsel to its client, Duos Technologies Group, Inc. (NASDAQ: DUOT), in connection with the Company's uplisting to the NASDAQ Capital Markets and the closing of the Company's underwritten public offering of 1,350,000 shares of common stock at an offering price of $6.00 per share, for aggregate gross proceeds of $8,100,000. The common stock began trading on the NASDAQ Capital Market under the symbol DUOT on February 13, 2020. ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering and The Benchmark Company acted as co-manager for the offering.

Lucosky Brookman serves as lead counsel for its client, Unique Logistics Holdings, Inc., in connection with a $12 Million senior secured factoring facility and acquisition financing. The financing permitted the management buyout of three internationally owned companies. Unique Logistics is a fully comprehensive, international logistics solutions business. Their services include air freight forwarding, ocean freight forwarding, purchase order management, insurance, customs brokerage and consulting, warehousing, and last mile delivery services. The company has been in business for over 35 years, generates over $100m in revenue annually, and is one of the top 50 NVOCCs in transpacific Eastbound shipping, with a strong presence in the US, Greater China, South East Asia, and Indian Subcontinent.

Lucosky Brookman LLP acted as lead counsel to its client, Blink Charging Co. (NASDAQ: BLNK), in connection with the Company's uplisting to the NASDAQ Capital Markets and the closing of the Company's underwritten public offering of common stock, for aggregate gross proceeds of $18.500,000.

Creatd, Inc. (NASDAQ: CRTD) priced its underwritten public offering of 1,725,000 units of securities at an offering price of $4.50 per unit. In connection with the offering, the Company's common stock and warrants began trading on the NASDAQ Capital Market on September 11, 2020, under the symbols "CRTD" and "CRTDW," respectively. The Company received gross proceeds of $7.7625 Million. Lucosky Brookman represented its client, The Benchmark Company, LLC, as book-running manager for the offering. Aegis Capital Corp. and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as co-managers for the offering.

Lucosky Brookman LLP successfully represented its client, SilverSun Technologies, Inc. in connection with SilverSun’s sale of its wholly owned subsidiary for $11.5 Million.

Lucosky Brookman LLP acted as lead counsel to its client, Duos Technologies Group, Inc. (NASDAQ: DUOT), in connection with the Company's private placement capital raise of $11 Million.

GeoVax Labs, Inc. (NASDAQ: GOVX, GOVXW), a biotechnology company developing human immunotherapies and vaccines against infectious diseases, closed its underwritten public offering of 2,560,000 units of its common stock, pre-funded warrants, and warrants for gross proceeds of $12.8 Million. The common stock and warrants began trading on The NASDAQ Capital Market on September 25, 2020, under the symbols “GOVX” and “GOVXW,” respectively. Lucosky Brookman represented the underwriter and book-running manager, Maxim Group LLC, in connection with the offering.

Lucosky Brookman LLP successfully represented its client, Akers Biosciences, Inc., in connection with a registered public offering of Akers common stock for proceeds of $6 Million.

Conversion Labs, Inc., (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, completes an equity investment by a select group of private investors and family offices, including investors David Blitzer and Wes Edens, for $3.5 Million. Lucosky Brookman acts as lead counsel for the Company in connection with its sale of 3,500 units (the “Units”), at a purchase price of $1,000 per Unit, each consisting of one share of Series B Convertible Preferred Stock of the Company, par value $0.0001 per share, and a warrant to purchase 2,000 shares of common stock, par value $0.0001 per share of the Company.

Lucosky Brookman LLP successfully represented its client, Spartan Capital Securities LLC, as Placement Agent, in connection with the registered direct offering of approximately $3.38 Million of BioHiTech Global, Inc. (NASDAQ: BHTG) common stock. The registered direct offering provided for the sale of approximately 1,875,000 shares of common stock at a price of $1.80 per share. The offering closed on September 9, 2019.

Lucosky Brookman LLP successfully represented its client, Spartan Capital Securities LLC, as Exclusive Placement Agent, in connection with the registered direct offering of approximately $1.00 Million of Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) (NASDAQ:HJLIW),common stock and warrants.

Lucosky Brookman LLP successfully represented its client, Spartan Capital Securities LLC, as Exclusive Placement Agent, in connection with the registered direct offering of approximately $1.00 Million of Hancock Jaffe Laboratories, Inc.(NASDAQ:HJLI) (NASDAQ:HJLIW),common stock and warrants. Under the terms of the deal, HJLI sold 1,886,800 shares of its common stock. In a concurrent private placement, HJLI has agreed to issue warrants to purchase up to an aggregate of 1,886,800 shares of common stock.

Lucosky Brookman represented its client Unique Logistics Holdings Inc. in connection with the Company’s merger with Innocap, Inc. ("INNO") (OTC: INNO) whereby Unique Logistics became a publicly-traded company. Simultaneously with the Merger, the Company entered into Securities Purchase Agreements with investors pursuant to which the Company sold to the Investors 10% secured subordinated convertible promissory notes, realizing gross proceeds of $2,000,000 and warrants to purchase shares of the Company's common stock.

Lucosky Brookman has successfully represented its client, GreenBox POS, an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions, to complete a private placement of approximately 3.8M restricted registered shares for aggregate net proceeds of $2.66 million to the Company at $0.80 cents per share.

Lucosky Brookman represents is client, NaturalShrimp, Inc., an aquaculture Company which has developed and patented the first commercially operational Recirculating Aquaculture System (RAS) for shrimp, in the closing of an asset acquisition.  Lucosky Brookman represented the Company in the $10 Million acquisition of the assets of Alder Aqua, formerly known as VeroBlue Farms in Webster City, Iowa, including but not limited to the real property, equipment, tanks, rolling stock, inventory, permits, customer lists, contracts and other such assets used in the operation of the business.

Lucosky Brookman represents its client, Spartan Capital Securities, LLC in connection with closing a $4 Million Registered Direct Offering of Pingtan Marine Enterprise Ltd. (Nasdaq: PME) Series A Convertible Preferred Shares.  Pingtan is a fishing company based in the People's Republic of China.  Spartan served as exclusive placement agent for this offering.

Lucosky Brookman LLP is pleased to share that its client Esports Entertainment Group, Inc. (Nasdaq: GMBL) has closed on the sale of $35 million 8.0% senior convertible notes in a private placement. The Notes are convertible into shares of common stock of the Company at a conversion price of $17.50 per share.  Lucosky Brookman acted as corporate and securities legal counsel to the Company.